Ninlaro Interactions
There are 329 drugs known to interact with Ninlaro (ixazomib), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 62 are major, and 267 are moderate.
- View all 329 medications that may interact with Ninlaro
- View Ninlaro alcohol/food interactions (1)
- View Ninlaro disease interactions (5)
Most frequently checked interactions
View interaction reports for Ninlaro (ixazomib) and the medicines listed below.
- acetaminophen
- acyclovir
- amlodipine
- atorvastatin
- cannabis
- Colace (docusate)
- Cymbalta (duloxetine)
- daratumumab
- dexamethasone
- Eliquis (apixaban)
- gabapentin
- hydrocodone
- levofloxacin
- lisinopril
- lorazepam
- metformin
- oxycodone
- Ozempic (semaglutide)
- pantoprazole
- Pomalyst (pomalidomide)
- potassium chloride
- Revlimid (lenalidomide)
- Singulair (montelukast)
- tamsulosin
- tramadol
- Tylenol (acetaminophen)
- Velcade (bortezomib)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- warfarin
Ninlaro alcohol/food interactions
There is 1 alcohol/food interaction with Ninlaro (ixazomib).
Ninlaro disease interactions
There are 5 disease interactions with Ninlaro (ixazomib) which include:
- gastrointestinal toxicities
- hepatic impairment
- peripheral neuropathy
- renal impairment
- thrombocytopenia
More about Ninlaro (ixazomib)
- Ninlaro consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: proteasome inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.